TCIM
SLDB icon

TIAA CREF Investment Management’s Solid Biosciences SLDB Stock Holding History

TIAA CREF Investment Management’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$204K Sell
1,476
-26
-2% -$6.51K ﹤0.01% 2880
2018
Q4 		$604K Hold
1,502
– – ﹤0.01% 2490
2018
Q3 		$1.06M Buy
1,502
+167
+13% +$105K ﹤0.01% 2392
2018
Q2 		$713K Buy
1,335
+433
+48% +$133K ﹤0.01% 2637
2018
Q1 		$101K Buy
+902
New +$305K ﹤0.01% 3013

Other funds holding SLDB

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

TIAA CREF Investment Management's SLDB Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Solid Biosciences (SLDB) stake by 1.7% in Q1 2019, selling an estimated $6.51K and leaving 1,476 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #2880.

TIAA CREF Investment Management first reported a position in SLDB in Q1 2018 and has held it in 5 quarters since. The position peaked at $1.06M in Q3 2018. 74 funds tracked by Wall St. Rank hold SLDB as of Q1 2019.

  • TIAA CREF Investment Management held 1,476 shares of Solid Biosciences worth $204K as of Q1 2019.
  • TIAA CREF Investment Management sold 26 Solid Biosciences shares in Q1 2019, an estimated $6.51K.
  • Solid Biosciences made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2880 holding.
  • TIAA CREF Investment Management first reported a position in Solid Biosciences in Q1 2018 and has held it in 5 quarters since.
  • TIAA CREF Investment Management's Solid Biosciences position peaked at $1.06M in Q3 2018.
  • 74 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.